Last10K.com

Milestone Scientific Inc. (MLSS) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

Milestone Scientific Inc.

CIK: 855683 Ticker: MLSS
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 16, 2022
Document Information [Line Items]  
Entity Central Index Key0000855683 
Entity Registrant NameMILESTONE SCIENTIFIC INC. 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Document Fiscal Period FocusQ1 
Document Fiscal Year Focus2022 
Document Type10-Q 
Document Quarterly Reporttrue 
Document Period End DateMar. 31, 2022 
Document Transition Reportfalse 
Entity File Number001-14053 
Entity Incorporation, State or Country CodeDE 
Entity Tax Identification Number13-3545623 
Entity Address, Address Line One425 Eagle Rock Avenue Suite 403 
Entity Address, City or TownRoseland 
Entity Address, State or ProvinceNJ 
Entity Address, Postal Zip Code07068 
City Area Code973 
Local Phone Number535-2717 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Title of 12(b) SecurityCommon Stock 
Trading SymbolMLSS 
Security Exchange NameNYSE 
Entity Common Stock, Shares Outstanding 68,432,335

View differences made from one quarter to another to evaluate Milestone Scientific Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Milestone Scientific Inc..

Continue

Assess how Milestone Scientific Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Milestone Scientific Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Cash Flow
Geography
Expense
Product
Other
Inside Milestone Scientific Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Changes In Stockholders' Equity (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Note 1 - Organization And Business
Note 1 - Organization And Business (Details Textual)
Note 10 - Segment And Geographic Data
Note 10 - Segment And Geographic Data (Details Textual)
Note 10 - Segment And Geographic Data (Tables)
Note 10 - Segment And Geographic Data - Summary By Reporting And Operating Segments (Details)
Note 10 - Segment And Geographic Data - Summary Of Operations By Geographic Area (Details)
Note 11 - Concentrations
Note 11 - Concentrations (Details Textual)
Note 12 - Related Party Transactions
Note 12 - Related Party Transactions (Details Textual)
Note 13 - Commitments
Note 13 - Commitments (Details Textual)
Note 13 - Commitments (Tables)
Note 13 - Commitments - Lease Expense (Details)
Note 14 - Subsequent Events
Note 14 - Subsequent Events (Details Textual)
Note 2 - Liquidity And Uncertainties
Note 2 - Liquidity And Uncertainties (Details Textual)
Note 3 - Summary Of Significant Accounting Policies
Note 3 - Summary Of Significant Accounting Policies (Details Textual)
Note 4 - Inventories
Note 4 - Inventories (Details Textual)
Note 4 - Inventories (Tables)
Note 4 - Inventories - Summary Of Inventories (Details)
Note 5 - Advances On Contracts
Note 5 - Advances On Contracts (Details Textual)
Note 6 - Investment In And Transactions With Equity Investees
Note 6 - Investment In And Transactions With Equity Investees (Details Textual)
Note 7 - Patents
Note 7 - Patents (Details Textual)
Note 7 - Patents (Tables)
Note 7 - Patents - Summary Of Patents (Details)
Note 8 - Stockholders' Equity
Note 8 - Stockholders' Equity (Details Textual)
Note 8 - Stockholders' Equity (Tables)
Note 8 - Stockholders' Equity - Schedule Of Restricted Stock (Details)
Note 8 - Stockholders' Equity - Summary Of Option Activity For Employees And Non-Employees (Details)
Note 8 - Stockholders' Equity - Summary Of Shares To Be Issued (Details)
Note 8 - Stockholders' Equity - Warrants (Details)
Note 9 - Income Taxes
Note 9 - Income Taxes (Details Textual)
Significant Accounting Policies (Policies)

Material Contracts, Statements, Certifications & more

Milestone Scientific Inc. provided additional information to their SEC Filing as exhibits

Ticker: MLSS
CIK: 855683
Form Type: 10-Q Quarterly Report
Accession Number: 0001437749-22-012645
Submitted to the SEC: Mon May 16 2022 4:35:41 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mlss/0001437749-22-012645.htm